● Recruiting

A Phase I Clinical Study of AHB - 171 in Healthy Participants(HP) and Chronic Hepatitis B (CHB) Participants

Condition: Chronic Hepatitis B Infection · Sponsor: Ausper Biopharma Co., Ltd.

PhasePhase 1

Planned participants110

Who can joinAll sexes, 18 Years to 65 Years

Healthy volunteersYes

About this study

The goal of this clinical trial is to evaluate the safety, tolerability, immunogenicity and Pharmacokinetics (PK) characteristics of AHB-171 Injection in healthy participants (Part A) and participants with chronic hepatitis B (CHB, Part B), and assess its preliminary efficacy in CHB participants.

This description comes directly from the study's public registry record.

Talk to the study team

Bella Lu · 0571-86959519 · clinicaltrial@ausperbio.com

Always discuss trial participation with your own doctor first.

Locations (2)

AusperBio Investigational Site	Ch’ang-ch’un, Jilin, China	Recruiting
AusperBio Investigational Site	Hangzhou, Zhejiang, China	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07511218